EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The Future of Microbiome Therapeutics

Milena Pitashny, Inbar Kesten, Dima Shlon, Dana Ben Hur, Haggai Bar-Yoseph

Drugs · 2025

DOI: 10.1007/s40265-024-02107-3 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drugs, 2025. Verfasst von Milena Pitashny und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Research Microbiome Center, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Microbiota, Gastrointestinal Microbiome. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Open access funding provided by Technion - Israel Institute of Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The human microbiome exerts profound influence over various biological processes within the body. Unlike many host determinants, it represents a readily accessible target for manipulation to promote health benefits. However, existing commercial microbiome-directed products often exhibit low efficacy. Advancements in technology are paving the way for the development of novel microbiome therapeutics, across a wide range of indications. In this narrative review, we provide an overview of state-of-the-art technologies in late-stage development, examining their advantages and limitations. By covering a spectrum, from fecal-derived products to live biotherapeutics, phage therapy, and synthetic biology, we illuminate the path toward the future of microbiome therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrobiotaGastrointestinal MicrobiomeHumansFecal Microbiota TransplantationPhage TherapyProbioticsSynthetic BiologyAnimals

Autor:innen und Institutionen

  • Clinical and Research Microbiome Center, Rambam Health Care Campus, Haifa, Israel.
  • Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Internal Medicine D, Rambam Health Care Campus, Haifa, Israel.
  • Internal Medicine H, Rambam Health Care Campus, Haifa, Israel.
  • Department of Gastroenterology, Rambam Health Care Campus, HaAliya HaShniya St 8, 3109601, Haifa, Israel.
  • Clinical and Research Microbiome Center, Rambam Health Care Campus, Haifa, Israel. haggaiby@gmail.com.

Förderung

  • Open access funding provided by Technion - Israel Institute of Technology

Zitieren

APA

Pitashny, M., Kesten, I., Shlon, D., Hur, D. B., & Bar-Yoseph, H. (2025). The Future of Microbiome Therapeutics. Drugs. https://doi.org/10.1007/s40265-024-02107-3

Vancouver

Pitashny M, Kesten I, Shlon D, Hur DB, Bar-Yoseph H. The Future of Microbiome Therapeutics. Drugs. 2025. doi:10.1007/s40265-024-02107-3

BibTeX
@article{Pitashny2025,
  author = {Pitashny, Milena and Kesten, Inbar and Shlon, Dima and Hur, Dana Ben and Bar-Yoseph, Haggai},
  title = {The Future of Microbiome Therapeutics},
  journal = {Drugs},
  year = {2025},
  doi = {10.1007/s40265-024-02107-3}
}
Kostenlos starten →